Biểu đồ giá cổ phiếu GSK
GSK Tài chính
GSK plc
$49.52
-1.84%
$-0.92
Khi đóng cửa: Aug 14, 16:00:00 GMT-4
$49.82
0.61%
$0.3
Phiên sau giờ: Aug 14, 20:00:00 GMT-4
Quay lại
GSK plc (GSK) Tài chính
Thống kê chính
Giá đóng cửa trước
$50.45
Giá mở cửa
$49.04
Phạm vi ngày
$48.86 - $49.82
Phạm vi 52 tuần
$38.63 - $61.7
Khối lượng
3.7M
Khối lượng trung bình
3.9M
Tỷ suất cổ tức
--
EPS (TTM)
3.15
Vốn hóa thị trường
$99.8B
GSK plc là gì?
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. The Company’s segments include Commercial Operations and Research and Development. The firm is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) with antibiotics. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development. The firm also engaged in ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody. The firm also owns HS235, a potential molecule for the treatment of pulmonary hypertension (PH).
